Age-adjusted level of circulating elastin as a cardiovascular risk factor in medical check-up individuals

Journal of Cardiovascular Medicine

Volumn 15, Issue 5, 2014, Pages 364-370

  Yamanaka, Hiroyuki ^a,b   Osaka, Motohisa ^a   Takayama, Morimasa ^a   Munakata, Kazuo ^a   Nejima, Jun ^b   Katayama, Masahiko ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TSURUMI UNIVERSITY   (Japan)

^c EISAI CO LTD   (Japan)

Author keywords

ageing; cardiovascular system; circulation; elastin; risk factors

Indexed keywords

CIRCULATING SOLUBLE ELASTIN; ELASTIN; GLUCOSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL INDICATOR; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERURICEMIA; LOW RISK POPULATION; MALE; MEDICAL EXAMINATION; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VERY ELDERLY; AGING; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES COMPLICATIONS; DOWN REGULATION; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DOWN-REGULATION; DYSLIPIDEMIAS; ELASTIN; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84899936168     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328360940b     Document Type: Article

References (37)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a 'set up' for vascular disease. Circulation 2003; 107:139-146.
2. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107:490-497.
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
4. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharm 2003; 57:195-202.
5. Giro MG, Davidson JM. Elastin. Meth Enzymol 1988; 163:656-673.
6. Rosenbloom J, Abrams WR, Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J 1993; 7:1208-1218.
7. Fülöp T, Wei SM, Robert L, et al. Determination of elastin peptides in normal and arteriosclerotic human sera by ELISA. Clin Physiol Biochem 1990; 8:273-282.
8. Lindholt JS, Heickendorff L, Henneberg EW, et al. Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1997; 14:12-16.
9. Viglio S, Annovazzi L, Luisetti M, et al. Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation. J Sep Sci 2007; 30:202-213.
10. Baydanoff S, Nicoloff G, Alexiev C. Age-related changes in the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects. Atherosclerosis 1987; 66:163-168.
11. Shinohara T, Suzuki K, Okada M, et al. Soluble elastin fragments in serum are elevated in acute aortic dissection. Arterioscler Thromb Vasc Biol 2003; 23:1839-1844.
12. Shinohara T, Okada M, Suzuki K, et al. Quantitative analysis for soluble elastin in circulation and cell culture fluids using monoclonal antibodybased sandwich immunoassay. J Immun Immunochem 2005; 26:189-202.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
14. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
16. Tinker D, Romero-Chapman N, Reiser K, et al. Elastin metabolism during recovery from impaired crosslink formation. Arch Biochem Biophys 1990; 278:326-332.
17. Bizbiz L, Alpérovitch A, Robert L, et al. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study. Atherosclerosis 1997; 131:73-78.
18. Qiu H, Depre C, Ghosh K, et al. Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates. Circulation 2007; 116:669-676.
19. Dollery CM, Owen CA, Sukhova GK, et al. Neutrophil elastase in human atherosclerotic plaques. Production by macrophages. Circulation 2003; 107:2829-2836.
20. Patel MI, Melrose J, Ghosh P, et al. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 1996; 24:82-92.
21. Lefevre M, Rucker RB. Aorta elastin turnover in normal and hypercholesterolemic Japanese quail. Biochim Biophys Acta 1980; 630:519-529.
22. Shapiro SD, Endicott SK, Province MA, et al. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J Clin Invest 1991; 87:1828-1834.
23. Gonçalves I, Moses J, Dias N, et al. Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke 2003; 34:616-622.
24. Akima T, Nakanishi K, Suzuki K, et al. Soluble elastin decreases in the progress of atheroma formation in human aorta. Circ J 2009; 73:2154-2162.
25. Katsunuma H, Shimizu K, Ebihara T, et al. Anti-atherosclerotic action of elastase-with special reference to its effect on elastic fibres. Age Ageing 1983; 12:183-194.
26. Seyama Y, Wachi H. Atherosclerosis and matrix dystrophy. J Atheroscler Thromb 2004; 11:236-245.
27. Zureik M, Robert L, Courbon D, et al. Serum elasetase activity, serum elastase inhibitors, and occurrence of carotid atherosclerotic plaques. The EVA study. Circulation 2002; 105:2638-2645.
28. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005; 46:454-462.
29. Todorovitch-Hunter L, Johnson DJ, Ranger P, et al. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study. Lab Invest 1988; 58:184-195.
30. Kramsch DM, Hollander W. The interaction of serum and arterial lipoproteins with elastin of the arterial intima and its role in the lipid accumulation in atherosclerotic plaques. J Clin Invest 1973; 52:236-247.
31. Shock A, Baum H, Kapasi MF, Bull FM, Quinn PJ. The susceptibility of elastin-fatty acid complexes to elastolytic enzymes. Matrix 1990; 10:179-185.
32. Stehouwer CDA, Henry RMA, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51:527-539.
33. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92:399-404.
34. Konova E, Baydanoff S, Atanasova M, Velkova A. Age-related changes in the glycation of human aortic elastin. Exp Geront 2004; 39:249-254.
35. Bhansing KJ, van Bon L, Janssen M, Radstake TRDJ. Gout: a clinical syndrome illustrated and discussed. Neth J Med 2010; 68:352-359.
36. Viazzi F, Leoncini G, Ratto E, Pontremoli R. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived. J Clin Hypertens 2006; 8:510-518.
37. Gaffo AL, Edwards NL, Saag KG. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther 2009; 11:240-246.